Belmont, CA, United States of America

XianYun Jiao

This inventor holds 9 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2007-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: XianYun Jiao. Retrieved from https://idiyas.com/inventor/xianyun-jiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 55.6

 

Average Co-Inventor Count = 15.8

ph-index = 3

Forward Citations = 80(Granted Patents)


Location History:

  • San Mateo, CA (US) (2007 - 2010)
  • Belmont, CA (US) (2010 - 2017)

Company Filing History:


Years Active: 2007-2017

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: XianYun Jiao: Innovator in Cancer Treatment

Introduction

XianYun Jiao is a prominent inventor based in Belmont, CA, specializing in the development of innovative compounds for cancer treatment. With a total of 9 patents to his name, he has made significant contributions to the field of medicinal chemistry.

Latest Patents

Among his latest patents are the "Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer." This invention provides MDM2 inhibitor compounds of Formula I, which are designed to target and inhibit the MDM2 protein, a key player in cancer cell proliferation.

Career Highlights

XianYun Jiao has established a successful career at Amgen Inc., a leading biotechnology company. His work focuses on creating novel therapeutic agents that can effectively combat various forms of cancer.

Collaborations

He has collaborated with notable colleagues, including Zice Fu and Julio Cesar Medina, to advance research and development in cancer therapies.

Conclusion

XianYun Jiao's innovative work in developing MDM2 inhibitors showcases his commitment to improving cancer treatment options. His contributions continue to impact the field of medicinal chemistry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…